跳至主要内容
临床试验/NL-OMON20352
NL-OMON20352尚未招募不适用

Optimalisation of the response to influenza virus vaccination in breast cancer and colorectal cancer patients immunocompromised due to chemotherapy.

niversity Medical Center0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
180

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with breast cancer treated FEC- or TAC-containing triweekly chemotherapy at moment of vaccination;
  • 2. Patients with colorectal cancer treated with Oxaliplatin-containing triweekly chemotherapy at moment of vaccination;

排除标准

  • 1. Fever at time of vaccination defined as a temperature of > 38.5 C;
  • 2. Previous/known allergic reaction to any of the components of the vaccines given, for example hypersensitivity to egg protein;

研究者

发起方
niversity Medical Center

相似试验